Black Bird Biotech, Inc.
BBBT · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $248 | $4,374 | $5,741 | $16,850 |
| - Cash | $44 | $500 | $53 | $1 |
| + Debt | $670 | $58 | $46 | $875 |
| Enterprise Value | $873 | $3,933 | $5,734 | $17,724 |
| Revenue | $83 | $104 | $58 | $18 |
| % Growth | -21% | 81.3% | 224.1% | – |
| Gross Profit | -$56 | $20 | $29 | -$0 |
| % Margin | -67.7% | 18.8% | 51% | -0.2% |
| EBITDA | -$1,199 | -$1,416 | -$684 | -$146 |
| % Margin | -1,452.5% | -1,355.9% | -1,187.9% | -823.7% |
| Net Income | -$1,659 | -$1,811 | -$692 | -$164 |
| % Margin | -2,009.1% | -1,734% | -1,200.6% | -920.8% |
| EPS Diluted | -0.005 | -0.009 | -0.006 | -0.001 |
| % Growth | 46.2% | -63.2% | -307.1% | – |
| Operating Cash Flow | -$1,033 | -$992 | -$619 | -$86 |
| Capital Expenditures | $0 | -$6 | -$0 | $0 |
| Free Cash Flow | -$1,033 | -$998 | -$619 | -$86 |